Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

A Study of PLX2853 in Advanced Malignancies.

NCT03297424

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States
  • Columbia University Medical Center New York, United States
  • South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
View Trial Details
Completed

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

NCT01991184

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +22 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
  • Willamette Valley Cancer Ctr - 520 Country Club Eugene, Oregon, United States
View Trial Details
Completed

Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.

NCT01805557

Conditions
Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B-cell Lymphoma Refractory, Hemic and Lymphatic Diseases, +10 more
Locations
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Ematologia Meldola, Forlì-Cesena, Italy
  • Clinica Humanitas Rozzano, Milano, Italy
  • ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia Milan, MI, Italy
  • CRO Aviano Aviano, Pordenone, Italy
View all 24 locations
View Trial Details
Completed

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

NCT03365791

Conditions
Adenocarcinoma Of Esophagus, Advanced Well-differentiated Neuroendocrine Tumors, Bronchial Neoplasms, +28 more
Locations
  • California Pacific Medical Center Drug Shipment (2) San Francisco, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Northwestern University Medical School Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma

NCT03682796

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions